(HQY) HealthEquity - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US42226A1079

HQY: Health, Savings, Accounts, Investment, Benefits, Advisory, Platforms

HealthEquity, Inc. (NASDAQ:HQY) is a leading provider of health savings and spending solutions, operating at the intersection of healthcare and financial services. The company offers a suite of cloud-based platforms designed to help individuals and employers manage health savings, spending, and benefits in a tax-advantaged manner. Its core offerings include Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs), all of which are complemented by a range of digital tools for making informed healthcare decisions, earning wellness incentives, and growing savings through investment options.

The company’s platform is built to simplify the complexities of healthcare financing. Individuals can use its tools to pay healthcare bills, access personalized benefit information, and make investment choices. HealthEquity also provides an automated investment advisory service called Advisor, which helps users optimize their HSA investments. Beyond its direct-to-consumer offerings, the company serves employers through a network of benefits brokers, consultants, and health plans, offering pre-tax commuter benefits and COBRA continuation services. This diversified approach positions HealthEquity as a one-stop-shop for health and wealth management.

From a financial perspective, HealthEquity operates with a market capitalization of approximately $9.66 billion, reflecting its significant scale in the HSA and consumer-directed benefits market. The company trades on the NASDAQ under the ticker symbol HQY and is classified under the Managed Health Care sub-industry. Its trailing P/E ratio of 102.31 and forward P/E of 30.77 indicate a growth-oriented valuation, while its price-to-book ratio of 4.57 and price-to-sales ratio of 8.79 highlight its premium positioning in the market. These metrics are critical for investors assessing the company’s growth potential versus its current valuation.

HealthEquity’s business model is driven by a combination of subscription fees, transaction fees, and investment-related revenue. The company has built a robust distribution network, leveraging direct sales, benefits brokers, and partnerships with health plans and retirement record-keepers. This multi-channel approach allows it to reach a broad audience, from individual consumers to large employers. Its platform-agnostic strategy ensures compatibility with various benefits administrators, further expanding its reach and scalability.

Investors should note that HealthEquity operates in a highly competitive and regulated environment. The company’s success is tied to its ability to innovate and differentiate its offerings in the HSA and consumer-directed benefits space. Its focus on user experience, seamless integration with healthcare providers, and robust investment options positions it well to capitalize on the growing trend of healthcare consumerism. However, risks such as regulatory changes, competition from fintech entrants, and economic sensitivity to healthcare spending trends remain

Additional Sources for HQY Stock

HQY Stock Overview

Market Cap in USD 9,766m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Managed Health Care
IPO / Inception 2014-07-31

HQY Stock Ratings

Growth 5y 38.7%
Fundamental 19.0%
Dividend 0.0%
Rel. Strength Industry 32.6
Analysts 4.5/5
Fair Price Momentum 97.33 USD
Fair Price DCF 18.85 USD

HQY Dividends

No Dividends Paid

HQY Growth Ratios

Growth Correlation 3m 64%
Growth Correlation 12m 62.2%
Growth Correlation 5y 53.9%
CAGR 5y 5.55%
CAGR/Max DD 5y 0.10
Sharpe Ratio 12m 0.90
Alpha 14.37
Beta 0.87
Volatility 31.39%
Current Volume 587.8k
Average Volume 20d 703.3k
What is the price of HQY stocks?
As of February 22, 2025, the stock is trading at USD 108.60 with a total of 587,776 shares traded.
Over the past week, the price has changed by -3.63%, over one month by +3.69%, over three months by +3.77% and over the past year by +35.63%.
Is HealthEquity a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, HealthEquity is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.98 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HQY as of February 2025 is 97.33. This means that HQY is currently overvalued and has a potential downside of -10.38%.
Is HQY a buy, sell or hold?
HealthEquity has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy HQY.
  • Strong Buy: 8
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for HQY stock price target?
According to ValueRays Forecast Model, HQY HealthEquity will be worth about 116 in February 2026. The stock is currently trading at 108.60. This means that the stock has a potential upside of +6.82%.
Issuer Forecast Upside
Wallstreet Target Price 114.3 5.2%
Analysts Target Price 113 4.1%
ValueRay Target Price 116 6.8%